Girod, M.; Geisler, A.; Hinze, L.; Elsner, L.; Dieringer, B.; Beling, A.; Kurreck, J.; Fechner, H.
Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320. Int. J. Mol. Sci. 2024, 25, 5618.
https://doi.org/10.3390/ijms25115618
AMA Style
Girod M, Geisler A, Hinze L, Elsner L, Dieringer B, Beling A, Kurreck J, Fechner H.
Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320. International Journal of Molecular Sciences. 2024; 25(11):5618.
https://doi.org/10.3390/ijms25115618
Chicago/Turabian Style
Girod, Maxim, Anja Geisler, Luisa Hinze, Leslie Elsner, Babette Dieringer, Antje Beling, Jens Kurreck, and Henry Fechner.
2024. "Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320" International Journal of Molecular Sciences 25, no. 11: 5618.
https://doi.org/10.3390/ijms25115618
APA Style
Girod, M., Geisler, A., Hinze, L., Elsner, L., Dieringer, B., Beling, A., Kurreck, J., & Fechner, H.
(2024). Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320. International Journal of Molecular Sciences, 25(11), 5618.
https://doi.org/10.3390/ijms25115618
